Therapy with the BPC-157 peptide for selected diseases of the genitourinary system 1.Urinary incontinence Urinary incontinence is defined as a process in which urine leakage is uncontrolled and involuntary, for example during coughing, sneezing, or physical exertion
Patients were included if they met all the following criteria: (1) new-onset type 2 diabetes diagnosed between 1 January 2006 and 31 December 2015, according to International Classification of Diseases, Revision 10 (ICD-10) code (Additional file 1: Table S1) or use of antidiabetic medications by the Anatomical Therapeutic Chemical (ATC) classification codes (Additional file 1: Table S2)
(10) Engel MG, Narayan S, Cui MH, Branch CA, Zhang X, Gandy SE, Ehrlich M, Huffman DM
A study [199] demonstrated that the presence of intra-myocardial hemorrhage (IMH) in patients with ST-segment elevation myocardial infarction who underwent interventional therapy reperfusion for the first time was related to residual myocardial iron at follow-up, suggesting a link between iron metabolism and reperfusion injury